11β-13,14-dihydro-15-keto Prostaglandin F2α-d9-前列腺素-ELISA_抗体_蛋白_核苷酸_试剂盒-深圳公海赌赌船官网登录网址科技有限公司

首页产品中心前列腺素

11β-13,14-dihydro-15-keto Prostaglandin F2α-d9

品牌：Cayman

官网链接

说明书

折扣/货期

货号：18787-100 µg	规格：100 µg	目录价：￥2128
货号：18787-50 µg	规格：50 µg	目录价：￥1134

产品详情

产品名称:

11β-13,14-dihydro-15-keto Prostaglandin F2α-d9

别名:

11-epi 13,14-dihydro-15-keto PGF2α-d9|11β-13,14-dihydro-15-keto PGF2α-d9

产品描述:

11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 (11β-13,14-dihydro-15-keto PGF2α-d9) is intended for use as an internal standard for the quantification of 11β-13,14-dihydro-15-keto PGF2α (Item No. 16540) by GC- or LC-MS. 11β-13,14-dihydro-15-keto PGF2α is a metabolite of prostaglandin D2 (PGD2; Item No. 12010) in the 15-hydroxy PGDH pathway.{11174,11176} Infusion or inhalation of tritiated PGD2 in normal males results in the appearance of peak levels of both 11β-PGF2α, as the immediate product, and 11β-13,14-dihydro-15-keto PGF2α in the plasma within 10 minutes.{11174} Homogenates of human lung metabolize PGD2 first to 11β-PGF2α and then to 11β-15-keto-PGF2α in the presence of NAD+, but not 11β-13,14-dihydro-15-keto PGF2α.{11176} Guinea pig liver and kidney homogenates metabolize PGD2 to 11β-13,14-dihydro-15-keto PGF2α, via 11β-PGF2α, in the presence of NAD+ and NADP+.{11176}

保存温度:

-20

运输温度:

-20

预期分子量:

363.5

产品形式:

A solution in methyl acetate

有效期:

365

纯度:

≥99% deuterated forms (d1-d9)